Technical Bulletin

Future ready Data Centre
“to go” for Actelion
Background
Actelion is a biopharmaceutical company with its corporate
headquarters in Allschwil/Basel, Switzerland. Actelion was
founded in 1997 and its shares have been listed on the
SWX Swiss Exchange with the ticker symbol ALTN since
2000. The company is focused on the discovery,
development and commercialisation of synthetic, small-
molecule drugs as innovative treatments to serve unmet
medical needs. Actelion has a proven track record in drug
discovery and has significant expertise in two research
platforms – G-protein coupled receptors (GPCRs), which
are proteins embedded in the cell wall that receive various
chemical messages and aspartyl proteases, a class of
natural enzymes. Actelion has subsidiaries in over 20
countries including the United States, Canada, Brazil,
Australia, Japan, Switzerland and a number of EU
countries. These subsidiaries provide or will provide
distribution, sales and marketing services.
Actelion
Pharmaceuticals Ltd
www.actelion.com
Location:
Allschwil, Switzerland
Vertical Market:
Pharmaceutical
Application:
Data Centre
www.panduit.com

Summary of content (3 pages)